U.S. Offers Pakistan Help In Creating Drug Regulatory Agency
This article was originally published in PharmAsia News
The United States has offered Pakistan's new government help in establishing a drug regulation system. Although Pakistan has no production plants that have the approval of the U.S. FDA, it exports about $484 million worth of medicines a year. U.S. Health and Human Services Secretary Michael Leavitt made the offer in meetings with Prime Minister Yousuf Raza Gilani and Health Minister Sherry Rehman. The assistance would include offering expertise in establishing best practices and setting up an FDA type of regulatory authority. (Click here for more
You may also be interested in...
AdvaMed’s VentConnect platform is expanding to support production of devices needed to treat COVID-19. Here’s what Eric Fanning, CEO of participating group the Aerospace Industries Association, said about the move.
Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.